Logo
x

Search

Subscribe Now

All Posts by Date

Top 20 Oncology Companies Based on 2020 Oncology Segment Revenue

Top 20 Oncology Companies Based on 2020 Oncology Segment Revenue

  • September 9, 2021
Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706- a Proposed Biosimilar Avastin (bevacizumab)

Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706- a Proposed Biosimilar Avasti...

  • September 9, 2021
AstraZeneca and Hutchmed Initiate P-III SANOVO Trial for Orpathys (savolitinib) + Tagrisso (osimertinib) as a 1L Therapy for Non-small Cell Lung Cancer in China

AstraZeneca and Hutchmed Initiate P-III SANOVO Trial for Orpathys (savolitinib) + Tagrisso (osimertinib) as a 1L Therapy for Non-s...

  • September 9, 2021
Sanofi Provides Update on P-III PEGASUS Trial of Rilzabrutinib for the Treatment of Pemphigus

Sanofi Provides Update on P-III PEGASUS Trial of Rilzabrutinib for the Treatment of Pemphigus

  • September 9, 2021
AstraZeneca Reports Results of PT027 (albuterol and budesonide) in P-III MANDALA and DENALI Trials for the Treatment of Asthma

AstraZeneca Reports Results of PT027 (albuterol and budesonide) in P-III MANDALA and DENALI Trials for the Treatment of Asthma

  • September 9, 2021
Cardiff Oncology Reports Results of Onvansertib in P-Ib/II Trial for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer

Cardiff Oncology Reports Results of Onvansertib in P-Ib/II Trial for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer

  • September 9, 2021
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.